July 30, 2017

Abiomed, Inc. (NASD:ABMD) Zacks Rank: 2-Buy

$146.25 USD (As of 07/28/2017) Style : Value: Growth: Momentum: VGM:

Target Price $160.00 Price, Consensus & Surprise

52 Week High-Low $149.34 - $95.14
20 Day Average
290,906
Volume

Beta 0.20
Market Cap 6.44 B
Dividend / Div Yld $0.00 / 0.00%
Industry Medical - Instru..

171 / 265 (Bot

Industry Rank
35%)

Proj. EPS Growth (Q1) 80.00%

Proj. EPS Growth (F1) 51.99%
P/E (F1) 82.24

Last EPS Surprise 7.14%

Avg. Last 4 Surprises 1.93%

Next Report Date 10/26/2017

Earnings ESP 8.33%

Agreement Estimate Revisions (60 Days) Magnitude Consensus Estimate Trend (60 Days)

Q1 Q2 F1 F2 Q1 Q2 F1 F2
# of Analysts 6 6 6 6 Current 0.36 0.48 1.78 2.53

# of Revisions 2 1 0 2 7 Days Ago 0.34 0.48 1.78 2.52

# Up 2 1 0 2 30 Days Ago 0.34 0.48 1.78 2.48

# Down 0 0 0 0 60 Days Ago 0.34 0.48 1.78 2.47

Trend of
% Revision Agreement: 100% 100% 100% Estimate
Revisions: +5.88% 0% 0% +2.43%

Industry Comparison Medical - Instru.. | Position in Industry: 2 of 77 Industry Peers

ABMD X Industry S&P 500 ARAY BABY ANGO

Hist. EPS Growth (3-5 yrs) 41.06% 13.98% 7.14% NA 32.40% 19.71%
Proj. Sales Growth (F1/F0) 28.11% 7.80% 4.93% 4.84% 32.23% 1.61%
Net Margin 16.13% -19.21% 9.71% -8.61% 4.20% 2.00%
Return on Equity 13.03% -31.48% 15.86% -61.49% 12.09% 5.19%
Debt/Capital 2.63% 4.35% 41.72% 54.45% 20.43% 15.01%
P/E (F1) 80.40 28.32 18.86 NA 21.09 24.18
Price/Sales (P/S) 13.27 3.30 2.47 1.00 2.66 1.72
Price/Book (P/B) 11.11 3.16 3.27 8.03 2.78 1.16
Price/Cash Flow (P/CF) 109.19 16.47 13.49 NA 16.47 11.62
YTD % Price Change 26.88% 2.83% 9.71% -4.35% 3.02% -3.02%

Description Medical > Medical Products > Medical - Instruments

Abiomed, Inc. is a developer, manufacturer and marketer of medical products designed to safely and effectively assist or replace the
pumping function of the failing heart. The company currently manufactures and sells the BVS-5000, a temporary heart assist device,
which is approved by the U.S. Food and Drug Administration for the temporary treatment of all patients with failing but potentially
recoverable hearts. The company is also engaged in research and development relating to other devices to support the pumping function
of the heart.

Learn More about Zacks Rank and Style Scores